# A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects

> **NCT00833781** · PHASE1,PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 15 (actual)

## Conditions studied

- HIV-1 Infection
- HIV Infections

## Interventions

- **BIOLOGICAL:** mRNA-transfected autologous dendritic cells
- **BIOLOGICAL:** autologous dendritic cells with no mRNA transfection

## Key facts

- **NCT ID:** NCT00833781
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-03-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00833781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00833781, "A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00833781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*